Wells Fargo & Company Rapt Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 21,469 shares of RAPT stock, worth $36,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,469

Previous 15,889 35.12%

Holding current value

$36,282

Previous $48,000 10.42%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.76 - $3.75 $9,820 - $20,925	5,580 Added 35.12%	21,469 $43,000
Q2 2024 Aug 13, 2024	SELL	$2.89 - $9.38 $9,831 - $31,910	-3,402 Reduced 17.64%	15,889 $48,000
Q1 2024 May 10, 2024	BUY	$6.87 - $26.45 $46,722 - $179,886	6,801 Added 54.45%	19,291 $173,000
Q4 2023 Feb 09, 2024	SELL	$11.28 - $25.46 $177,942 - $401,631	-15,775 Reduced 55.81%	12,490 $310,000
Q3 2023 Nov 13, 2023	SELL	$16.34 - $24.66 $153,661 - $231,902	-9,404 Reduced 24.96%	28,265 $469,000
Q2 2023 Aug 15, 2023	SELL	$16.06 - $21.61 $20,524 - $27,617	-1,278 Reduced 3.28%	37,669 $704,000
Q1 2023 May 12, 2023	BUY	$17.19 - $30.8 $669,498 - $1.2 Million	38,947 New	38,947 $714,000
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $3,663 - $6,213	204 Added 36.11%	769 $19,000
Q2 2022 Aug 12, 2022	SELL	$10.26 - $23.59 $59,056 - $135,784	-5,756 Reduced 91.06%	565 $10,000
Q1 2022 May 16, 2022	SELL	$17.02 - $40.22 $119,208 - $281,700	-7,004 Reduced 52.56%	6,321 $139,000
Q4 2021 Feb 14, 2022	BUY	$29.5 - $39.5 $384,739 - $515,159	13,042 Added 4608.48%	13,325 $489,000
Q3 2021 Nov 15, 2021	SELL	$29.86 - $39.47 $4,986 - $6,591	-167 Reduced 37.11%	283 $9,000
Q2 2021 Aug 16, 2021	SELL	$17.99 - $40.02 $39,613 - $88,124	-2,202 Reduced 83.03%	450 $14,000
Q1 2021 May 13, 2021	SELL	$16.0 - $24.46 $441,200 - $674,484	-27,575 Reduced 91.23%	2,652 $58,000
Q4 2020 Feb 09, 2021	SELL	$15.89 - $40.87 $313,795 - $807,100	-19,748 Reduced 39.52%	30,227 $597,000
Q3 2020 Nov 05, 2020	BUY	$21.6 - $37.5 $163,728 - $284,250	7,580 Added 17.88%	49,975 $1.61 Million
Q2 2020 Aug 13, 2020	BUY	$14.16 - $32.85 $411,093 - $953,701	29,032 Added 217.26%	42,395 $1.23 Million
Q1 2020 May 14, 2020	BUY	$11.86 - $48.86 $158,485 - $652,916	13,363 New	13,363 $284,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $50.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Rapt Therapeutics, Inc. Transaction History